Europlasma SA (ALEUP) Stock Statistics & Valuation Metrics

Europlasma SA has a market cap or net worth of €7.39M. The enterprise value is €18.25M.

Europlasma SA has 1,448,672,100 shares outstanding. The number of shares has decreased by -2.65% in one year.

Europlasma SA’s return on equity (ROE) is 1.47 and return on invested capital (ROIC) is -115.56%.

The current PE Ratio of Europlasma SA is -2.37. Europlasma SA’s PEG ratio is >-0.01.

In the last 12 months, Europlasma SA had revenue of 42.45M and earned -15.29M in profits. Earnings per share was -0.02.

In the last 12 months, operating cash flow was -11.47M and capital expenditures -1.52M, giving a free cash flow of -12.98M billion.

Europlasma SA pays an annual dividend of ―, resulting in a dividend yield of ―

Europlasma SA upcoming earnings date is Oct 29, 2024, TBA (Confirmed).

Europlasma SA as a current ratio of 0.77, with Debt / Equity ratio of -131.31%

In the past 12 months, Europlasma SA has paid -2.75M in taxes.

Europlasma SA EV to EBITDA ratio is -19.24, with an EV/FCF ratio of -3.89.

Europlasma SA has €1.75M in cash and marketable securities with €13.67M in debt, giving a net cash position of €11.92M billion.

Gross margin is -49.85%, with operating margin of -51.40%, and net profit margin of -36.02%.

The average price target for Europlasma SA is ―, which is 11.43% higher than the current price. The consensus rating is ―